clinical research prime

Postpartum Depression Treatment

• We are testing an oral medication for treating postpartum depression (PPD) – it is already FDA-approved as an IV infusion.

• Women ages 15 to 45.

• Must have experienced a major depressive episode starting no earlier than week 26 of pregnancy and within 4 weeks after delivery.

• Participants will receive study related treatment at no cost and will be compensated for time and travel.